Product Information
ISENTRESS HD 600 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $34.5150 per EA under NDC 00006308001. Its NADAC has been published 446 times since Mar 21, 2018.
FDA first approved this application on Oct 12, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006308001
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RALTEGRAVIR POTASSIUMApproval Type
New Drug (NDA)
FDA Application
NDA022145FDA Approved
10/12/2007
TE Code
AB
On Market Since
5/26/2017
Pharmacological Classes
Price Statistics
The NADAC for ISENTRESS HD 600 MG TABLET has been published 446 times since Mar 21, 2018, and over the history we have for it it has risen 42.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $34.5150 per EA |
|---|---|
| All-time high | $34.5789 (May 13, 2026) |
| All-time low | $24.1496 (Mar 21, 2018) |
| 52-week high | $34.5789 |
| 52-week low | $33.7482 |
| Median price | $29.5736 |
| Average price | $29.4277 |
| Largest weekly change | +5.0% (Jan 15, 2020) |
| Weeks tracked | 446 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the RALTEGRAVIR market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Merck Sharp & Dohme LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
RALTEGRAVIR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ISENTRESS HD 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISENTRESS HD 600 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $34.5150 per EA (NDC 00006308001), effective Sep 30, 2026.
How has the price of ISENTRESS HD 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for ISENTRESS HD 600 MG TABLET has risen 42.9%. It has been tracked across 446 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for ISENTRESS HD 600 MG TABLET?
Since Mar 21, 2018, the NADAC for ISENTRESS HD 600 MG TABLET has ranged from a low of $24.1496 (Mar 21, 2018) to a high of $34.5789 (May 13, 2026), with a median of $29.5736 per EA.
Are there cheaper alternatives to ISENTRESS HD 600 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ISENTRESS HD 600 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ISENTRESS HD 600 MG TABLET?
ISENTRESS HD 600 MG TABLET (NDC 00006308001) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.